Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
This study has been completed.
Study NCT00015769   Information provided by National Institutes of Health Clinical Center (CC)
First Received: May 4, 2001   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders
Interventions listed in this trial
levetiracetam
Additional drug interventions recognized in this trial
Etiracetam
Piracetam
More general drug interventions related to this trial
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Nootropic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services